Fusion Antibodies PLC
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, and diagnostic companies. The company has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom. Show More...
-
Website https://www.fusionantibodies.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 6.10 GBX
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-03 2011-03 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 TTM Earnings Per Share GBP 0.05 0.010 -0.04 -0.06 -0.04 Dividends GBP Payout Ratio % * Shares Mil 22.0 22.0 22.0 16.0 22.0 22.0 Book Value Per Share * GBP 0.08 0.26 0.19 Free Cash Flow Per Share * GBP -0.010 -0.09 Return on Assets % -22.94 103.07 5.96 -14.95 -18.8 -16.22 Financial Leverage (Average) 2.19 1.28 1.26 1.1 1.16 1.18 Return on Equity % -50.27 141.93 7.59 -16.9 -21.2 -18.47 Return on Invested Capital % -49.94 141.98 7.62 -16.58 -20.94 -17.87 Interest Coverage -148.55 55.82 205.74 -145.31 -370.9 -110.83 Current Ratio 1.84 1.77 2.16 9.66 4.15 3.95 Quick Ratio 1.73 1.77 1.99 9.5 3.82 3.57 Debt/Equity 0.010 0.010 0.03